StockData
Quoin Pharmaceuticals Ltd. logo

Quoin Pharmaceuticals Ltd. (QNRX) stock

QNRXNasdaqPharmaceutical Preparations
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$3.56+0.20 (+5.95%)

Close on Nov 18, 2026Market cap $7.15MP/E –Yield –

Quoin Pharmaceuticals ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2020 it was -$4.24M.

Annual ebitda

PeriodPeriod endValueChange
FY2020Dec 31, 2020-$4.24M–
FY2019Dec 31, 2019-$6.35M–
FY2017Dec 31, 2017-$6.94M–

More Quoin Pharmaceuticals figures

See a number that looks wrong?